Mirae Asset Global ETFs Holdings
ELEV

Mirae Asset Global ETFs Holdings’s Elevation Oncology ELEV Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,433
Closed -$7.63K – 3075
2025
Q1 		$7.63K Buy
29,433
+1,404
+5% +$802 ﹤0.01% 3031
2024
Q4 		$15.8K Buy
28,029
+1,341
+5% +$792 ﹤0.01% 3015
2024
Q3 		$16K Buy
+26,688
New +$39.6K ﹤0.01% 3023

Other funds holding ELEV

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ELEV Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Elevation Oncology (ELEV) in Q2 2025, closing a stake of 29,433 shares — an estimated $7.63K sold.

Mirae Asset Global ETFs Holdings first reported a position in ELEV in Q3 2024 and held it in 3 quarters. The position peaked at $16K in Q3 2024. 65 funds tracked by Wall St. Rank hold ELEV as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Elevation Oncology position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 29,433 Elevation Oncology shares in Q2 2025, an estimated $7.63K.
  • Mirae Asset Global ETFs Holdings first reported a position in Elevation Oncology in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Elevation Oncology position peaked at $16K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Elevation Oncology as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.